Patient and case management for COVID-19

ECDC resources on patient and case management for COVID-19, including protective equipment, diagnosis, prevention and vaccines.

Patient/case management
Diagnosis
Protective equipment
Vaccines

Case management
COVID-19

Patient and case management for COVID-19

Guidance on ending the isolation period for people with COVID-19, third update

Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update

Infection prevention and control and preparedness for COVID-19 in healthcare settings - sixth update

COVID-19 infection prevention and control measures for primary care, including general practitioner practices, dental clinics and pharmacy settings: first update

Infection prevention and control and surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UK

Case definition for coronavirus disease 2019 (COVID-19), as of 3 December 2020

Diagnostic testing and screening for SARS-CoV-2

Evaluation of the SARS-CoV-2 testing policy in Belgium from June to December 2021

Considerations for the use of antibody tests for SARS-CoV-2 – first update

Options for the use of rapid antigen tests for COVID-19 in the EU/EEA - first update

Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings

Considerations for the use of saliva as sample material for COVID-19 testing

Non-pharmaceutical interventions against COVID-19

Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern

Guidelines for the implementation of non-pharmaceutical interventions against COVID-19

Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – eleventh update: resurgence of cases

Infographic: Use of gloves in healthcare and non-healthcare settings in the context of COVID-19

Use of gloves in healthcare and non-healthcare settings in the context of the COVID 19 pandemic

Treatment and pharmaceutical prophylaxis of COVID-19

Vaccination Portal : COVID-19 vaccines

COVID-19 vaccination

Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022

Public health considerations and evidence to support decisions on the implementation of a second mRNA COVID-19 vaccine booster dose

Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA

Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update

Considerations for the use of antibody tests for SARS-CoV-2 – first update

Featured links

Latest

Featured links

Latest

Featured links

Latest

Featured links

Spotlight

Featured links

Spotlight

Patient and case management for COVID-19

Guidance on ending the isolation period for people with COVID-19, third update

Contact tracing in the European Union: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases – fourth update

Infection prevention and control and preparedness for COVID-19 in healthcare settings - sixth update

COVID-19 infection prevention and control measures for primary care, including general practitioner practices, dental clinics and pharmacy settings: first update

Infection prevention and control and surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UK

Case definition for coronavirus disease 2019 (COVID-19), as of 3 December 2020

Diagnostic testing and screening for SARS-CoV-2

Evaluation of the SARS-CoV-2 testing policy in Belgium from June to December 2021

Considerations for the use of antibody tests for SARS-CoV-2 – first update

Options for the use of rapid antigen tests for COVID-19 in the EU/EEA - first update

Considerations on the use of rapid antigen detection (including self-) tests for SARS-CoV-2 in occupational settings

Considerations for the use of saliva as sample material for COVID-19 testing

Non-pharmaceutical interventions against COVID-19

Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern

Guidelines for the implementation of non-pharmaceutical interventions against COVID-19

Rapid Risk Assessment: Coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – eleventh update: resurgence of cases

Infographic: Use of gloves in healthcare and non-healthcare settings in the context of COVID-19

Use of gloves in healthcare and non-healthcare settings in the context of the COVID 19 pandemic

Treatment and pharmaceutical prophylaxis of COVID-19

Vaccination Portal : COVID-19 vaccines

COVID-19 vaccination

Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022

Public health considerations and evidence to support decisions on the implementation of a second mRNA COVID-19 vaccine booster dose

Overview of the implementation of COVID-19 vaccination strategies and deployment plans in the EU/EEA

Interim analysis of COVID-19 vaccine effectiveness against Severe Acute Respiratory Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update

Considerations for the use of antibody tests for SARS-CoV-2 – first update

Follow us: